5 of Last Week's Biggest Winners
What's better than momentum? Mo' momentum.
Let's take a closer look at five of this past week's biggest scorchers.
|May 25||Weekly Gain||My Watchlist|
|Ship Finance International (NYS: SFL)||$16.45||32%||Add|
|Splunk (NAS: SPLK)||$35.93||24%||Add|
|Pacific Biosciences (NAS: PACB)||$2.60||23%||Add|
|US Airways (NYS: LCC)||$12.30||22%||Add|
|Tudou (NAS: TUDO)||$36.09||20%||Add|
Ship Finance International was the New York Stock Exchange's biggest gainer, soaring 32% after posting better than expected quarterly results. The shipper also boosted its already-generous dividend.
Recent IPO Splunk -- the poster child of "big data" -- made "big money" for investors after Barclays initiated coverage of the tech upstart with an "overweight" rating.
Pacific Biosciences of California gained ground after an article in TheStreet.com's Stockpickr website touted the gene sequencer as one of five prime buyout candidates.
US Airways took off after JPMorgan Chase airline analyst Jamie Baker bumped the airline's price target from $14.50 to $17. The entire sector is benefiting from a sharp drop in gasoline prices in recent months.
Finally, Tudou posted strong gains after a strong quarterly report. China's second largest video-streaming website posted a narrower deficit than the pros were expecting on a hearty 77% surge in revenue. Tudou is in the process of being acquired by its larger rival, but buoyant fundamentals always come in handy in case a deal falls apart or the buyer starts to get cold feet.
More winners for you
It was a great week for these five stocks. If you want to get an early read on some of tomorrow's major gainers there's a special report on three hidden winners in a booming industry. The report is free -- like this article -- but it won't be around forever, so check it out now.
At the time this article was published Longtime Fool contributor Rick Munarriz calls them as he sees them. He does not own shares in any of the stocks in this story. Rick is also part of theRule Breakersnewsletter research team, seeking out tomorrow's ultimate growth stocks a day early.Motley Fool newsletter serviceshave recommended buying shares of Pacific Biosciences of California. The Motley Fool has adisclosure policy. We Fools may not all hold the same opinions, but we all believe thatconsidering a diverse range of insightsmakes us better investors. Try any of our Foolish newsletter servicesfree for 30 days.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.